234 related articles for article (PubMed ID: 31881923)
1. Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
Faust CL; Crotti M; Moses A; Oguttu D; Wamboko A; Adriko M; Adekanle EK; Kabatereine N; Tukahebwa EM; Norton AJ; Gower CM; Webster JP; Lamberton PHL
Parasit Vectors; 2019 Dec; 12(1):607. PubMed ID: 31881923
[TBL] [Abstract][Full Text] [Related]
2. New insights into the molecular epidemiology and population genetics of Schistosoma mansoni in Ugandan pre-school children and mothers.
Betson M; Sousa-Figueiredo JC; Kabatereine NB; Stothard JR
PLoS Negl Trop Dis; 2013; 7(12):e2561. PubMed ID: 24349589
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme.
Gower CM; Gehre F; Marques SR; Lamberton PHL; Lwambo NJ; Webster JP
Parasit Vectors; 2017 Dec; 10(1):593. PubMed ID: 29197426
[TBL] [Abstract][Full Text] [Related]
4. Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.
French MD; Churcher TS; Basáñez MG; Norton AJ; Lwambo NJ; Webster JP
Acta Trop; 2013 Nov; 128(2):196-205. PubMed ID: 22440199
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of Schistosoma mansoni reveals limited population structure and possible praziquantel drug selection pressure within Ugandan hot-spot communities.
Vianney TJ; Berger DJ; Doyle SR; Sankaranarayanan G; Serubanja J; Nakawungu PK; Besigye F; Sanya RE; Holroyd N; Allan F; Webb EL; Elliott AM; Berriman M; Cotton JA
PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010188. PubMed ID: 35981002
[TBL] [Abstract][Full Text] [Related]
6. Regular treatments of praziquantel do not impact on the genetic make-up of Schistosoma mansoni in Northern Senegal.
Huyse T; Van den Broeck F; Jombart T; Webster BL; Diaw O; Volckaert FA; Balloux F; Rollinson D; Polman K
Infect Genet Evol; 2013 Aug; 18():100-5. PubMed ID: 23684792
[TBL] [Abstract][Full Text] [Related]
7. Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.
Coeli R; Baba EH; Araujo N; Coelho PM; Oliveira G
PLoS Negl Trop Dis; 2013; 7(12):e2596. PubMed ID: 24367712
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration.
Berger DJ; Crellen T; Lamberton PHL; Allan F; Tracey A; Noonan JD; Kabatereine NB; Tukahebwa EM; Adriko M; Holroyd N; Webster JP; Berriman M; Cotton JA
Nat Commun; 2021 Aug; 12(1):4776. PubMed ID: 34362894
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni population structure and persistence after praziquantel treatment in two villages of Bahia, Brazil.
Blanton RE; Blank WA; Costa JM; Carmo TM; Reis EA; Silva LK; Barbosa LM; Test MR; Reis MG
Int J Parasitol; 2011 Aug; 41(10):1093-9. PubMed ID: 21784077
[TBL] [Abstract][Full Text] [Related]
10. Does mass drug administration affect Schistosoma mansoni infection trends in West Dembia district, Northwest Ethiopia?
Zeleke AJ; Addisu A; Bayih AG; Tweya H; Timire C; Techilo W; Kamau EM; Vogt F; Verdonck K
J Infect Dev Ctries; 2020 Jun; 14(6.1):72S-77S. PubMed ID: 32614800
[TBL] [Abstract][Full Text] [Related]
11. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
13. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
Barbosa LM; Reis EA; Dos Santos CR; Costa JM; Carmo TM; Aminu PT; Pitanga TN; Ponce-Terashima R; Blank WA; Silva LK; Reis MG; Blanton RE
Int J Parasitol; 2016 May; 46(5-6):343-50. PubMed ID: 26953255
[TBL] [Abstract][Full Text] [Related]
14. Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.
Norton AJ; Gower CM; Lamberton PH; Webster BL; Lwambo NJ; Blair L; Fenwick A; Webster JP
Am J Trop Med Hyg; 2010 Oct; 83(4):951-7. PubMed ID: 20889898
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel.
Kemal M; Tadesse G; Esmael A; Abay SM; Kebede T
BMC Res Notes; 2019 Apr; 12(1):211. PubMed ID: 30953565
[TBL] [Abstract][Full Text] [Related]
17. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
Lamberton PHL; Faust CL; Webster JP
Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
[TBL] [Abstract][Full Text] [Related]
18. Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania.
Mishra P; Colombe S; Paul N; Mlingi J; Tosiri I; Aristide C; Gao J; Kashangaki P; Nagai H; Kalluvya SE; de Dood CJ; Corstjens PL; Mngara J; van Dam GJ; Downs JA
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007844. PubMed ID: 31751333
[TBL] [Abstract][Full Text] [Related]
19. Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome.
Schneeberger PHH; Coulibaly JT; Panic G; Daubenberger C; Gueuning M; Frey JE; Keiser J
Parasit Vectors; 2018 Mar; 11(1):168. PubMed ID: 29530088
[TBL] [Abstract][Full Text] [Related]
20. Effect of maternal Schistosoma mansoni infection and praziquantel treatment during pregnancy on Schistosoma mansoni infection and immune responsiveness among offspring at age five years.
Tweyongyere R; Naniima P; Mawa PA; Jones FM; Webb EL; Cose S; Dunne DW; Elliott AM
PLoS Negl Trop Dis; 2013; 7(10):e2501. PubMed ID: 24147175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
